Eurofins Scientific News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

13.05.21	Eurofins Supports Reopening of UK Travel With Launch of Affordable Day 2 & 8 Testing Services (Businesswire)
07.05.21	EAG erweitert Prüfdienstleistungen für Medizinprodukte mit neuem Labor (Businesswire)
07.05.21	EAG Expands Medical Device Testing Services with New Laboratory (Businesswire)
26.04.21	Eurofins Subsidiary empowerDX and Uber Team up, Offer At-home COVID-19 Testing Kits via On-demand Delivery in More Than Two Dozen U.S. Cities (Businesswire)
13.04.21	Eurofins Covid Testing Services Ltd (ECTS) Supports Reopening UK Travel by Making PCR Testing Affordable for All (Businesswire)
22.03.21	Eurofins Technologies Launches an Enhanced Variant of Concern-Discriminating PCR Test Including the South African Variant (B.1.351) (Businesswire)
12.03.21	Eurofins Adds Virus Variant Detection to its SARS-CoV-2 Monitoring Solution for Wastewater, Surface, Air and Worn Masks (Businesswire)
10.03.21	Eurofins Launches empowerDX COVID-19 Home Collection Kit on Amazon (Businesswire)
01.03.21	Nation’s PFAS Leader, Eurofins, Expands Reporting to 75 Compounds (Businesswire)
01.03.21	Eurofins Announces the launch of an At-Home COVID-19 PCR Test kit available direct to consumers, without prescription (Businesswire)
01.03.21	Eurofins Announces the launch of an At-Home COVID-19 PCR Test kit available direct to consumers, without prescription (Businesswire)
18.02.21	Eurofins Scientific Announces Acquisition of Beacon Discovery, Substantially Expanding Its Integrated Drug Discovery Capabilities and Expertise (Businesswire)
17.02.21	Eurofins Adds Virus Variant Distinction to Its SARS-CoV-2 Monitoring Solution for Wastewater, Food and Environmental Surfaces (Businesswire)
16.02.21	Eurofins Forensics Adds Significant COVID-19 Testing Capacity to the UK With Home Testing Roll-Out (Businesswire)
11.02.21	Eurofins Launches Quantitative Antibody Test to Measure Immune Response to COVID-19 and Vaccines (Businesswire)
03.02.21	Eurofins spendet 100.000 PCR-Schnelltests zum Nachweis der SARS-CoV-2 Varianten B.1.1.7 (ex. GB), B.1.351 (ex. Südafrika) und B1.1.248 (ex. Brasilien) an Krankenhäuser weltweit (PR Newswire)
02.02.21	Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world (PR Newswire)
02.02.21	Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world (PR Newswire)
02.02.21	Eurofins Donates 100,000 Fast PCR Tests to Detect SARS-CoV-2 Variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B.1.1.248 (ex. Brazil) to Hospitals Around the World (Businesswire)
28.01.21	Eurofins Offers a New Molecular Solution to Detect SARS-CoV-2 variants B.1.1.7 (UK) and B.1.351 (South Africa) (Businesswire)
25.01.21	Eurofins Achieved Revenues in Excess of EUR 5.4bn in 2020, After Continued Momentum in December Across Both Its Core Business and COVID-19 Related Activities (Businesswire)
15.01.21	Eurofins, weltweit führender Anbieter von analytischen Prüfungen, erweitert seine weltweiten Prüf- und Zertifizierungskapazitäten für Gesichtsmasken (Businesswire)
11.01.21	Eurofins GeneScan Technologies Announces AOAC PTM Accreditation for the VIRSeek SARS-CoV-2 Detection Workflow on Environmental Surfaces under the AOAC SARS-CoV-2 Emergency Response Validation Program (Businesswire)
28.12.20	Eurofins Genomics Launches Cost-Effective SARS-CoV-2 full-length Viral Genome Sequencing Services Essential in the Identification of Viral Mutations (Businesswire)
22.12.20	Eurofins Launches COVID-19 PCR Tests With At-Home Self-Sampling Options in Europe and Donates Sequencing Capacity to Identify VUI-2020-12/01 Strain Reported to Spread Faster in the UK (Businesswire)
15.12.20	Eurofins Raises Its 2020 Objectives After Strong Momentum in Its Core Business, as Well as in COVID-19 Related Activities in October and November (Businesswire)
14.12.20	Eurofins Technologies Launches New and Improved Lateral Flow Device Product Line for Allergen Detection in Foodstuffs and Environmental Samples (Businesswire)
14.12.20	Eurofins Launches a Rapid SARS-CoV-2 Antigen Test and a RT-PCR Test in a Self-Sampled, Gargling Format (Businesswire)
09.12.20	EAG Laboratories Announces Latest Advancement in Transmission Electron Microscopy (Businesswire)
09.12.20	Eurofins BioPharma Product Testing Italy erweitert Viruzid-Testkapazitäten mit neuem, speziell eingerichtetem Labor (Businesswire)
09.12.20	Eurofins BioPharma Product Testing Italy Expands Virucidal Testing Capacity With New Dedicated Laboratory (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Eurofins Scientific SE

Aktien Top/Flop

Meistgelesene Nachrichten